Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study

Christ, E R; Cummings, M H; Lumb, P J; Crook, M A; Sönksen, P H; Russell-Jones, D L (1999). Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study. Clinical endocrinology, 51(2), pp. 173-9. Oxford: Blackwell Scientific Publications 10.1046/j.1365-2265.1999.00751.x

Full text not available from this repository. (Request a copy)

Patients with adult GH-deficiency are thought to have an increased risk of cardiovascular disease. Sialic acid (SA) concentrations have been proposed as a marker of atherosclerotic disease probably related to an inflammatory response of the arterial wall. SA as a marker of cardiovascular disease in adult GH-deficiency and its relation to changes in fasting lipid profile and hormone concentrations have not yet been investigated.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition

UniBE Contributor:

Christ, Emanuel

ISSN:

0300-0664

Publisher:

Blackwell Scientific Publications

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:23

Last Modified:

17 Mar 2015 22:49

Publisher DOI:

10.1046/j.1365-2265.1999.00751.x

PubMed ID:

10468987

Web of Science ID:

000082023600008

URI:

https://boris.unibe.ch/id/eprint/37233 (FactScience: 207245)

Actions (login required)

Edit item Edit item
Provide Feedback